class action lawsuit

NuScale Power faces securities fraud lawsuit over failing to disclose risks associated with a $495 million ENTRA1 deal. Stock fell 12.4% after November disclosure.

SDM investors can join securities fraud class action alleging market manipulation through social media misinformation. Deadline to submit lead plaintiff motions is March 16, 2026.

Ramaco Resources faces class action lawsuit alleging executives made false statements about Brook Mine operations, claiming mining activity had commenced when it hadn't.

Securities fraud lawsuits filed against four public companies for alleged false statements. Investors must file lead plaintiff motions by April 3-6, 2026, to participate.

Kyndryl faces securities fraud lawsuit after CFO and General Counsel departed, triggering 54.9% stock drop. SEC investigating cash management and internal control weaknesses.

Class action lawsuit filed against Snowflake for allegedly making misleading statements about business impact while concealing product efficiency changes and pricing adjustments between June 2023 and February 2024.

Corcept Therapeutics faces securities lawsuit alleging misrepresentation of relacorilant clinical data and FDA approval prospects, while withholding known regulatory risks from investors.

Class action lawsuit filed against agilon health for allegedly making false statements about 2026 financial guidance and misrepresenting risk reduction initiatives' financial impact.

Varonis Systems faces class action lawsuit for allegedly making false statements about SaaS conversion capabilities, causing inflated stock prices during February-October 2025.

Class action lawsuit filed against Franklin BSP Realty Trust alleging false statements about dividend sustainability. Covers investors who purchased shares November 2024-February 2026.

Portnoy Law Firm sues Corcept Therapeutics over alleged misrepresentations about drug candidate relacorilant, following FDA rejection that caused stock to plummet 50%.

LAKE faces securities class action for alleged misstatements about operational performance and tariff strategies. Investors have until April 24, 2026 deadline to join.

Class action lawsuits filed against PayPal for misleading revenue projections and REGENXBIO for concealing gene therapy safety concerns, both triggering significant stock declines.

PayPal faces securities fraud lawsuit alleging material misstatements about revenue projections. Stock dropped 20.3% after CEO replacement and missed earnings disclosure.

Portnoy Law Firm sues Oracle on behalf of investors who suffered losses between June-December 2025 amid stock volatility and major AI infrastructure spending announcements.

NuScale Power faces shareholder lawsuit alleging false statements about ENTRA1 partnership qualifications and undisclosed risks. Stock dropped 12% after revealing $495M payment and $532M quarterly loss.

Navan IPO investors with losses over $100,000 have until April 24, 2026 to file for lead plaintiff status in a class action alleging the company concealed marketing expense increases before going public.

Ultragenyx faces securities lawsuit over delayed disclosure of failed Phase 3 trial. Investors must file lead plaintiff claims by April 6, 2026.

Kyndryl faces securities lawsuit after disclosing internal control weaknesses and delayed 10-Q filing. Stock dropped 21.8% following CFO and General Counsel departures.

BellRing Brands faces securities lawsuit alleging material non-disclosure from November 2024 to August 2025. Stock fell 52% after two guidance cuts amid retail inventory reductions and competition.